small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
  1. Professionals

Noori Torabi

Of Counsel

San Francisco

+1 415-591-1537

Let's Connect

Email
vCard
  • Full Bio PDFPDF
    • Email
    • LinkedIn
    • Facebook
    • Twitter
    Share this page
  • Overview
  • Credentials
  • Insights & News

Noori is a patent litigator who focuses her practice on representing pharmaceutical companies in Hatch-Waxman and biologics infringement cases. As a registered patent attorney with a B.S. and M.S. in biotechnology and a Ph.D. in molecular biology, she excels at simplifying complex technology issues for her clients. 

Noori’s patent litigation practice focuses on the pharmaceutical and biotechnology industries. She also represents her clients in post-grant proceedings, such as inter partes reviews, and provides counsel on IP due diligence in connection with various corporate transactions.

Noori has experience in all stages of district court litigation and post-grant proceedings including trial. As a member of multiple trial teams, Noori plays a key role in all stages of litigation, from developing case strategies, constructing invalidity and non-infringement defenses, conducting discovery including taking and defending depositions, and drafting dispositive motions, to preparing and direct-examining trial witnesses. Her extensive knowledge of patent law, combined with her technical background and Ph.D. in molecular biology, enhance her ability to consult and defend biotech and generic pharmaceutical companies in matters concerning an array of scientific issues.

In addition to her trial work, Noori advises clients on patent validity and infringement, provides freedom-to-operate analyses, conducts due diligence investigations, and offers strategic advice aligned with clients’ business objectives.

While earning her Ph.D. in molecular biology from Princeton University, Noori investigated the genetic basis of complex hereditary traits in yeast. She designed and performed various experimental and computational techniques, including high throughput phenotyping and genotyping of extremely large numbers of progeny from a cross between two yeast strains. Noori published four peer-reviewed articles in Nature and PLoS Genetics.

Noori is actively involved in pro bono work. In particular, she has worked on cases involving voting rights, immigration and education advocacy. She also regularly volunteers to help immigrants apply for asylum or citizenship.

Noori was named to Best Lawyers: Ones to Watch for Intellectual Property Law (2021-2023) and Patent Litigation in 2023.

Noori received her J.D., cum laude, from New York University School of Law in 2015, where she was a member of the NYU Law Intellectual Property and Entertainment Law Society and competition advocacy editor for the NYU Law Moot Court Board. She received her Ph.D. in molecular biology from Princeton University in 2012. Noori graduated first in her class from the University of Tehran in 2007 with a B.S. and M.S. in biotechnology.

Capabilities

Intellectual Property
Litigation/Trials
Patent Litigation
Medical Devices
Life Sciences

Credentials

Education

Noori received her B.S. and M.S. in Biotechnology from the University of Tehran in 2007, where she graduated first in her class. Noori received her Ph.D. in Molecular Biology from Princeton University in 2012, and received her J.D., cum laude, from New York University School of Law in 2015, where she was a member of the NYU Law Intellectual Property and Entertainment Law Society and competition advocacy editor for the NYU Law Moot Court Board.

    Admissions
    • Patent and Trademark Office
    • California
    • New York
    Languages
    • Farsi

    Related Insights & News

    • K. Vidal, M. Rueckheim, N. Torabi; “Silicon Valley”; Inside Counsel (2017). 
    • I.M. Ehrenreich, J.S. Bloom, N. Torabi, X. Wang, Y. Jia, and L. Kruglyak; Genetic architecture of highly complex chemical resistance traits across four yeast strains; PLoS Genetics e1002570 (2012).
    • N. Torabi, and L. Kruglyak; Genetic Basis of Hidden Phenotypic Variation Revealed by Increased Translational Readthrough in Yeast; PLoS Genetics 8(3) e1002546 (2012).
    • N. Torabi, and L. Kruglyak; Variants in SUP45 and TRM10 underlie natural variation in translation termination efficiency inS. cerevisiae. PLoS Genetics 7(7): e1002211 (2011).
    • I.M. Ehrenreich, N. Torabi, Y. Jia, J. Kent, S. Martis, J.A. Shapiro, D. Gresham, A.A. Caudy, and L. Kruglyak; Dissection of genetically complex traits with extremely large pools of yeast segregants. Nature (2010).
    Sponsorship
    Winston & Strawn Sponsors ChIPs 2024 Global Summit

    October 16, 2024

    Recognitions
    Winston & Strawn Attorneys Recognized in Best Lawyers: Ones to Watch in America 2023

    August 18, 2022

    Client Alert
    Functional Genus Claims Directed to Chimeric Antigen Receptors on T-Cells (CAR-T) Were Invalid for Lack of Written Description

    November 12, 2021

    Client Alert
    Chief Scientific Officer’s Contradictory Statements to the FDA and the Patent Office Rendered the Patent Covering Epinephrine Formulations Unenforceable

    October 18, 2021

    Client Alert
    The Language “Shall Be the Property Of” Is a Promise of Future Assignment—Not a Present Automatic Transfer of Intellectual Property Rights

    August 30, 2021

    Recognitions
    Winston & Strawn Attorneys Recognized in Best Lawyers: Ones to Watch in America 2022

    August 19, 2021

    Recognitions
    Winston Women Recognized in the 2021 Women in the Law edition of Best Lawyers

    July 1, 2021

    Client Alert
    Anticipation Finding Based on PTAB’s Claim Interpretation Deprived the Patentee of Due Notice

    February 10, 2021

    Client Alert
    Contracting Away Rights to Use a Mark Does Not Preclude a Petitioner From Challenging the Mark Before the Trademark Trial and Appeal Board

    August 24, 2020

    Recognitions
    Winston & Strawn Attorneys Recognized in Best Lawyers: Ones to Watch 2021

    August 20, 2020

    Webinar
    Judicial Panel: PTAB’s LEAP Initiative for NextGen Lawyers

    May 29, 2020

    Client Alert
    Intrinsic Evidence of Statements in Patent Specification May Be Sufficient to Determine Patentability at the Rule 12(b)(6) Stage Under Alice Step One Without Consulting Prior Art

    April 17, 2020

    View All Insights & News

    Capabilities

    Intellectual Property
    Litigation/Trials
    Patent Litigation
    Medical Devices
    Life Sciences
    Logo
    facebookinstagramlinkedintwitteryoutube

    Copyright © 2025. Winston & Strawn LLP

    AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising